Advertisement
Logos iRiS
Logos iRiS

The Nutshell

» cell & molecular biology, policy and funding

Daily News Roundup

Most Recent

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

image: Debate over RNA Transcription

Debate over RNA Transcription

By | March 19, 2012

Researchers question earlier findings of a new mechanism for gene regulation.

2 Comments

image: A FASTer FDA?

A FASTer FDA?

By | March 19, 2012

A new bill recently debated in the US Congress seeks to streamline the approval process for drugs.

0 Comments

image: Top Science Policy Concerns

Top Science Policy Concerns

By | March 13, 2012

A selection of 40 top science policy questions that need to be addressed were selected and published by researchers last week.

2 Comments

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.

4 Comments

image: Publishers Fight Open Access Bill

Publishers Fight Open Access Bill

By | March 6, 2012

The Federal Research Public Access Act faces stiff opposition from the Association American of Publishers.

8 Comments

image: H5N1 Insiders Speak Out

H5N1 Insiders Speak Out

By | March 6, 2012

NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.

0 Comments

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  4. Locating Language within the Brain
Advertisement
Gilson
Gilson
Advertisement
LabX
LabX
RayBioTech